Morbidity of diverting ileostomy for rectal cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program

Mehraneh D. Jafari, Wissam J Halabi, Fariba Jafari, Vinh Q. Nguyen, Michael J. Stamos, Joseph C. Carmichael, Steven D. Mills, Alessio Pigazzi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

There is controversy regarding the potential benefits of diverting ileostomy after low anterior resection (LAR). This study aims to examine the morbidity associated with diverting ileostomy in rectal cancer. A retrospective review of LAR cases was performed using the American College of Surgeons National Surgical Quality Improvement Program (2005 to 2011). Patients who underwent LAR with and without diversion were selected. Demographics, intraoperative events, and postoperative complications were reviewed. Among the 6337 cases sampled, 991 (16%) received a diverting ileostomy. Patients who were diverted were younger (60 vs 63 years), predominantly male (64 vs 53%), and more likely to have received pre-operative radiation (39 vs 12%). There was no significant difference in steroid use, weight loss, or intraoperative transfusion. Postoperatively, there was no significant difference in length of stay, rate of septic complications, wound infections, and mortality. The rate of reoperation was lower in the diverted group (4.5 vs 6.9%). Diversion was associated with a higher risk-adjusted rate of acute renal failure (OR 2.4; 95% CI (1.2, 4.6); P <0.05). The use of diverting ileostomy reduces the rate of reoperation but is associated with an increased risk of acute renal insufficiency. These findings emphasize the need for refinement of patient selection and close follow-up to limit morbidity.

Original languageEnglish (US)
Pages (from-to)1034-1039
Number of pages6
JournalAmerican Surgeon
Volume79
Issue number10
StatePublished - Oct 1 2013
Externally publishedYes

Fingerprint

Ileostomy
Rectal Neoplasms
Quality Improvement
Morbidity
Reoperation
Acute Kidney Injury
Intraoperative Complications
Wound Infection
Patient Selection
Weight Loss
Length of Stay
Steroids
Demography
Radiation
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Jafari, M. D., Halabi, W. J., Jafari, F., Nguyen, V. Q., Stamos, M. J., Carmichael, J. C., ... Pigazzi, A. (2013). Morbidity of diverting ileostomy for rectal cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program. American Surgeon, 79(10), 1034-1039.

Morbidity of diverting ileostomy for rectal cancer : Analysis of the American College of Surgeons National Surgical Quality Improvement Program. / Jafari, Mehraneh D.; Halabi, Wissam J; Jafari, Fariba; Nguyen, Vinh Q.; Stamos, Michael J.; Carmichael, Joseph C.; Mills, Steven D.; Pigazzi, Alessio.

In: American Surgeon, Vol. 79, No. 10, 01.10.2013, p. 1034-1039.

Research output: Contribution to journalArticle

Jafari, MD, Halabi, WJ, Jafari, F, Nguyen, VQ, Stamos, MJ, Carmichael, JC, Mills, SD & Pigazzi, A 2013, 'Morbidity of diverting ileostomy for rectal cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program', American Surgeon, vol. 79, no. 10, pp. 1034-1039.
Jafari, Mehraneh D. ; Halabi, Wissam J ; Jafari, Fariba ; Nguyen, Vinh Q. ; Stamos, Michael J. ; Carmichael, Joseph C. ; Mills, Steven D. ; Pigazzi, Alessio. / Morbidity of diverting ileostomy for rectal cancer : Analysis of the American College of Surgeons National Surgical Quality Improvement Program. In: American Surgeon. 2013 ; Vol. 79, No. 10. pp. 1034-1039.
@article{25bb9ea7d68b44cc908f0e57dc32446c,
title = "Morbidity of diverting ileostomy for rectal cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program",
abstract = "There is controversy regarding the potential benefits of diverting ileostomy after low anterior resection (LAR). This study aims to examine the morbidity associated with diverting ileostomy in rectal cancer. A retrospective review of LAR cases was performed using the American College of Surgeons National Surgical Quality Improvement Program (2005 to 2011). Patients who underwent LAR with and without diversion were selected. Demographics, intraoperative events, and postoperative complications were reviewed. Among the 6337 cases sampled, 991 (16{\%}) received a diverting ileostomy. Patients who were diverted were younger (60 vs 63 years), predominantly male (64 vs 53{\%}), and more likely to have received pre-operative radiation (39 vs 12{\%}). There was no significant difference in steroid use, weight loss, or intraoperative transfusion. Postoperatively, there was no significant difference in length of stay, rate of septic complications, wound infections, and mortality. The rate of reoperation was lower in the diverted group (4.5 vs 6.9{\%}). Diversion was associated with a higher risk-adjusted rate of acute renal failure (OR 2.4; 95{\%} CI (1.2, 4.6); P <0.05). The use of diverting ileostomy reduces the rate of reoperation but is associated with an increased risk of acute renal insufficiency. These findings emphasize the need for refinement of patient selection and close follow-up to limit morbidity.",
author = "Jafari, {Mehraneh D.} and Halabi, {Wissam J} and Fariba Jafari and Nguyen, {Vinh Q.} and Stamos, {Michael J.} and Carmichael, {Joseph C.} and Mills, {Steven D.} and Alessio Pigazzi",
year = "2013",
month = "10",
day = "1",
language = "English (US)",
volume = "79",
pages = "1034--1039",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "10",

}

TY - JOUR

T1 - Morbidity of diverting ileostomy for rectal cancer

T2 - Analysis of the American College of Surgeons National Surgical Quality Improvement Program

AU - Jafari, Mehraneh D.

AU - Halabi, Wissam J

AU - Jafari, Fariba

AU - Nguyen, Vinh Q.

AU - Stamos, Michael J.

AU - Carmichael, Joseph C.

AU - Mills, Steven D.

AU - Pigazzi, Alessio

PY - 2013/10/1

Y1 - 2013/10/1

N2 - There is controversy regarding the potential benefits of diverting ileostomy after low anterior resection (LAR). This study aims to examine the morbidity associated with diverting ileostomy in rectal cancer. A retrospective review of LAR cases was performed using the American College of Surgeons National Surgical Quality Improvement Program (2005 to 2011). Patients who underwent LAR with and without diversion were selected. Demographics, intraoperative events, and postoperative complications were reviewed. Among the 6337 cases sampled, 991 (16%) received a diverting ileostomy. Patients who were diverted were younger (60 vs 63 years), predominantly male (64 vs 53%), and more likely to have received pre-operative radiation (39 vs 12%). There was no significant difference in steroid use, weight loss, or intraoperative transfusion. Postoperatively, there was no significant difference in length of stay, rate of septic complications, wound infections, and mortality. The rate of reoperation was lower in the diverted group (4.5 vs 6.9%). Diversion was associated with a higher risk-adjusted rate of acute renal failure (OR 2.4; 95% CI (1.2, 4.6); P <0.05). The use of diverting ileostomy reduces the rate of reoperation but is associated with an increased risk of acute renal insufficiency. These findings emphasize the need for refinement of patient selection and close follow-up to limit morbidity.

AB - There is controversy regarding the potential benefits of diverting ileostomy after low anterior resection (LAR). This study aims to examine the morbidity associated with diverting ileostomy in rectal cancer. A retrospective review of LAR cases was performed using the American College of Surgeons National Surgical Quality Improvement Program (2005 to 2011). Patients who underwent LAR with and without diversion were selected. Demographics, intraoperative events, and postoperative complications were reviewed. Among the 6337 cases sampled, 991 (16%) received a diverting ileostomy. Patients who were diverted were younger (60 vs 63 years), predominantly male (64 vs 53%), and more likely to have received pre-operative radiation (39 vs 12%). There was no significant difference in steroid use, weight loss, or intraoperative transfusion. Postoperatively, there was no significant difference in length of stay, rate of septic complications, wound infections, and mortality. The rate of reoperation was lower in the diverted group (4.5 vs 6.9%). Diversion was associated with a higher risk-adjusted rate of acute renal failure (OR 2.4; 95% CI (1.2, 4.6); P <0.05). The use of diverting ileostomy reduces the rate of reoperation but is associated with an increased risk of acute renal insufficiency. These findings emphasize the need for refinement of patient selection and close follow-up to limit morbidity.

UR - http://www.scopus.com/inward/record.url?scp=84885599977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885599977&partnerID=8YFLogxK

M3 - Article

C2 - 24160794

AN - SCOPUS:84885599977

VL - 79

SP - 1034

EP - 1039

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 10

ER -